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THE effect of exogenous RNA on many cellular functions
has been studied in a variety of eukaryotic cells but there
are few reports on macrophages. In the present study, it is
demonstrated that cytoplasmatic RNA extracted from rat
macrophages stimulated with Escherichia coli lipopoly-
saccharide (LPS), referred to as L-RNA, induced the
release of TNF-t and IL-1 from monolayers of peritoneal
resident macrophages. The activity of L-RNA was not
altered by polymyxin B but was abolished by ribonuclease
(RNase) pretreatment, indicating the absence of LPS con-
tamination and that the integrity of the polynucleotide
chain is essential for this activity. Both the poly A(--) and
poly A(+) fractions obtained from L-RNA applied to
oligo(dT)-cellulose chromatography induced TNF-0t and
IL-1 release. The L-RNA-induced cytokine release was
inhibited by dexamethasone and seemed to be dependent
on protein synthesis since this effect was abolished by
cycloheximide or actinomycin-D. The LPS-stimulated
macrophages, when pre-incubated with [5-3H]-uridine,
secreted a trichloroacetic acid (TCA) precipitable material
which was sensitive to RNase and KOH hydrolysis, sug-
gesting that the material is RNA. This substance was also
released from macrophage monolayers stimulated with
IL-lfl but not with TNF-t, IL-6 or IL-8. The substance
secreted (3H-RNA) sediments in the 4-5S region ofa 5-20%
sucrose gradient. These results show that L-RNA induces
cytokine secretion by macrophage monolayers and sup-
port the idea that, during inflammation, stimulated macro-
phages could release RNA which may further induce the
release of cytokines by the resident cell population.
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Introduction
There is considerable evidence indicating that
exogenously supplied RNA molecules can be
incorporated into eukaryotic cells and can exert a
variety of biological effects both in vitro and in
vivo.
1-5 Cell differentiation, genetic transformation
and immunological effects induced by exogenous
RNA have been investigated over the past few
years. For example, RNA isolated from the
endoderm of normal embryos of the amphibian
A mbystoma mexicanum causes the differentiation of
mutant heart tissue into functional, contractile
cardiac muscle.
6 The genetic nutritional deficiencies
of a strain ofA spergillus nidulans have been corrected
by genetic transformation using RNA extracted
from the wild strain of this fungus. Recently, the
authors demonstrated the transfer, to human
lymphocytes, of cellular immunoreactivity to a
highly conserved and immunodominant, synthetic
epitope of the glycoprotein 41 of HIV-1, by using
RNA isolated from animals immunized with this
synthetic peptide.
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The effect of exogenous RNA has also been
detected in vivo. The direct injection of purified
mRNA for the bacterial enzyme chloramphenicol
acetyl transferase (CAT) into mouse skeletal
muscle results in significant CAT activity in these
muscle cells. Similarly, the injection of synthetic
mRNA for the Wnt oncogene family induces
cellular differentiation in Xenopus embryos, asso-
ciated with the formation of specific embryonic
structures.
1 The RNA obtained from the lymphoid
organs of animals immunized with carcinoma
antigens from human colon induces memory
T-lymphocytes against these tumour antigens in
vivo.
1
It is now becoming clear that the cytokines
constitute a link between cellular injury or
recognition of non-self and the development of the
inflammatory and/or immune response. Among the
cytokines, interleukin 1 (IL-1) and tumour necrosis
factor-o (TNF-o) play an important role in
triggering and in the maintenance of these
events. 12’13 Although several cells release cytokines,
the resident macrophages can be considered the
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most active cytokine secreting cells. 14’1s When
activated by exogenous and/or endogenous stimuli,
these macrophages release various cytokines,
including TNF-, IL-1, IL-6 and IL-8, which
induce the local and systemic events of the defence
response.
16,17
Recently, it has been suggested that RNA may
function as an intercellular mediator, acting over
short distances, leading to the possibility of the
transfer of biological information from one cell to
another via RNA molecules.
18
In the present study, we investigated whether
RNA extracted from LPS-activated macrophages
could stimulate the release ofTNF- and IL-1 from
naive macrophages in culture. We also investigated
whether macrophages stimulated by endotoxin
released RNA into the culture medium. The results
of the present investigation are consistent with the
idea that RNA may be involved as an intercellular
modulator of cytokine release from macrophages.
Materials and Methods
Preparation of macrophage monolayers: Rat peritoneal
cavities were stimulated by the injection of a 3%
thioglycollate solution (10ml/animal). Four days
later, the peritoneal macrophages were harvested
in RPMI medium and allowed to adhere to plastic
tissue culture dishes for 1 h at 37C, in an
atmosphere of air containing 5% CO2. The
monolayers were then washed three times with
phosphate buffered saline (PBS), pH 7.4, and
incubated for 1 h at 37C in RPMI medium
containing 10/,g/ml of Escherichia coli lipopoly-
saccharide (LPS). The supernatants were discarded
and the monolayers washed a further three times
with PBS. The cells were harvested with a
disposable rubber policeman and were used for
RNA extraction after centrifugation (1000 x g for
10 rain).
RNA extraction: Cytoplasmic RNA was extracted
from LPS-stimulated macrophages using the cold
phenol method described by White and De Lucca.
19
The macrophage pellet was homogenized in Tris-
HC1 buffer, pH 9.0, containing 0.01 M KC1 and
0.25 M sucrose (2.5 ml/g macrophage pellet, wet
weight) and centrifuged at 12 000 x g, for 15 min
at 4C. The supernatant was diluted two-fold with
the homogenization buffer and used as the source of
cytoplasmic RNA.
The supernatant was deproteinized by the
addition of an equal volume of 88% (v/v) phenol
containing 0.05% bentonite. The mixture was
shaken for 10 min and then centrifuged at 2 000 x g
for 10 min at 4C. The phenol phase was discarded
and the phenol treatment repeated twice. An equal
volume of 88% phenol-chloroform (1:1, v/v)
solution was added to the aqueous phase of the
phenol treatment. The mixture was shaken for
5 min at room temperature and centrifuged at
2000 x g for 10min at 4C. The RNA was
precipitated by the addition of crystalline NaC1 to
the final aqueous phase, to a final concentration of
0.1 M, plus 2.5 volumes of cold 96% ethanol. The
solution was left for 18 h at -20C and the
precipitated RNA was collected by centrifugation
and stored under ethanol at -20C until use.
The concentration of RNA was calculated by
measuring absorbance at 260 nm (1 absorbance
unit 40/zg of RNA/ml). Only those preparations
ofRNA with a ratio A260/a280 of about 1.9-2.0 were
used. The RNA preparations obtained from
LPS-stimulated macrophages are referred to as
L-RNA. Samples of cytoplasmic RNA obtained
from non-stimulated macrophage monolayers by
the same extraction procedure are referred to as
normal RNA (N-RNA).
The integrity of the RNA was routinely
evaluated using SDS-polyacrylamide gel elec-
trophoresis according to Bertolini and De Lucca.2
The gels were fixed in acetic acid and scanned for
absorbance at 260nm in a spectrophotometer
equipped with a linear transport.
Oligo(dT)-cellulose chromatography: The poly(A)-con-
taining RNA (poly A(4-)-RNA) and the poly(a)-
lacking RNA (poly A(--)-RNA) fractions were
separated from the bulk of the cytoplasmic RNA
(total RNA) by affinity chromatography on an
oligo(dT)-cellulose column as described by Aviv
and Leder. 21
Enzymatic treatment ofL-RNA: The L-RNA prepara-
tions were subjected to enzymatic treatment using
a mixture containing ribonuclease T (EC 3.1.27.3;
guanyloRNase) and bovine pancreatic ribonuclease
(EC 3.1.27.5; RNase type I-A). The enzymes were
diluted in 0.85% NaC1 in the ratio of 1/,g of each
RNase to 10/.zg L-RNA and the mixture incubated
at 37C for 30 min.
Polymyxin B treatment of L-RNA: Samples of L-RNA
(500/,g/ml) were p!:eincubated at 37C for 30 min
with polymyxin B (100#g/ml). The RNA was
recovered by ethanol precipitation followed by
centrifugation (2000 x g, at 4C for 25min).
Samples of LPS (10/zg/ml) were also preincubated
with polymyxin B.
Treatment of macrophage monolayers with L-RNA or
N-RNA: Macrophage monolayers (2 x 107 cells/
well) obtained as described previously were
cultured in 2 ml of RPMI medium supplemented
with 10% foetal calf serum, 2 mM L-glutamine,
100 units/ml penicillin, and 100/,g/ml streptomy-
cin, for 2h at 37C in an atmosphere of air
containing 5% CO2. The non-adherent cells were
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then removed by washing with RPMI medium.
Two of the following stimuli were added to each
well: LPS (5 #g/ml); L-RNA (25 #g/ml); L-RNA
(25/ig/ml) submitted to enzymatic or polymyxin B
pretreatment; N-RNA (25 g/ml); poly A(+)-L-
RNA (0.5/.tg/ml), and poly A( )-L-RNA
(25/,g/ml). After 90 min incubation at 37C, the
supernatants were discarded and the cells washed
three times with RPMI, followed by a final 6 h
incubation period in RPMI medium (1.5 ml/well).
For TNF or IL-1 assay, the cell-free incubation
fluids were subsequently filtered through 0.22
Millipore membranes and stored at -70C until
tested. Control wells were incubated with RPMI
medium alone.
To investigate the effects of actinomycin-D
(10/lg/ml), cycloheximide (10 #g/ml) and dexa-
methasone (3 #g/ml) on the release of TNF and
IL-1 by L-RNA-stimulated macrophage mono-
layers, the drugs were added to the incubation
medium 30 min before the stimuli and throughout
the stimulation period.
TNF activity assay: The TNF content of the RNA
macrophage supernatants was measured using a
highly TNF-sensitive cell line, WEHI 164 clone 13,
as described elsewhere.
22 Briefly, WEHI cells were
seeded in 96-well microplates at a concentration of
4 104 cells/well in 50/.tl of supplemented RPMI.
Fifty/tl of serially diluted crude supernatant were
added in quadruplicate to the cells. The plates were
incubated for 20h at 37C in a 5% CO2-air
incubator. Ten #1 of 3-[4,5-dimethylthiazol-2-yl]-
2,5-diphenyltetrazolium bromide (MTT) solution
(5 mg/ml PBS) were added to each well and the
plates incubated for an additional 4h. One
hundred #1 of isopropanol containing 0.04 N HCI
were then added to each well. Fifteen min later, the
degree of cell lysis was evaluated spectrophoto-
metrically (570nm) using an enzyme-linked im-
munoassay analyser.
Owing to the unavailability of rat TNF, standard
curves were obtained with mrTNF-0; the TNF
content of the assayed material was calculated by
comparison with standard amounts. The results are
given as the means of data obtained from at least
three different experiments. In some experiments, a
rabbit anti-mrTNF antibody was used to demon-
strate the specificity of the assay. The results are
expressed in international units (IU) of TNF/ml.
IL- activity assay: The IL-1 concentrations in
supernatants of RNA-stimulated macrophage
monolayers were measured using the thymocyte
co-mitogenic assay.
23 Briefly, thymocytes obtained
from the thymus of C3H/HeJ mice were plated in
96-well microplates at concentrations of 5 105
cells/well, in 100/.tl of supplemented RPMI (see
above). One hundred/.tl of serially diluted crude
supernatant, with or without concanavalin A (Con
A; 0.1-1/ig/well), were added to the incubation
medium, and the plates incubated for 72 h at 37C
in a 5% CO2-air incubator. [3H]-Thymidine
(0.5/.tCi/well) was then added and the plates
incubated for an additional 8 h. IL-1 concentrations
were calculated by interpolating the values from
standard curves constructed with rhuIL-1/ (0.2-
20 IU/well). The results are expressed as IU of
IL-1/ml.
Secretion of RNA by macrophages stimulated with LPS or
cytokines: The detection of RNA in the supernatants
of macrophage monolayers was performed using
[5-3H]-uridine as a specific precursor of RNA
synthesis, according to Kolodny et al. 24 Peritoneal
macrophages, obtained from thioglycollate treated
rats, were cultured in 12-well tissue culture plates
at a concentration of 2 x 10 cells/well, in 2 ml of
supplemented RPMI medium. The ceils were
allowed to adhere for 1 h at 37C in a 5% CO2-air
incubator. The nonadherent cells were removed by
washing with RPMI medium, and the macrophage
monolayers were incubated with 2 ml of medium
containing [5-3H]-uridine (5/lCi/ml) for 2 h. The
supernatants were then discarded and the cells
washed three times with RPMI medium. To each
well 2 ml of the following stimuli were added:
LPS (0.1-10#g/ml), rhuIL-lfl (10-10-10-8 M),
rhuTNF-0 (10-1-10
-8 M), rhulL-6 (10-1-
10
-8 M) and rhulL-8 (10-1-10
-8 M). Control
wells were incubated with RPMI medium alone.
The cell cultures were then incubated for a final 6 h
period. After incubation, the supernatants were
removed and centrifuged at 10 000 g for 30 min.
The RNA was precipitated with 25% TCA at 4C
for at least I h. The precipitated radioactive material
was filtered on a Millipore system using 0.45/.tm
membranes, followed by washing with 5% TCA.
Finally, the radioactivity present in the membranes
was detected in a liquid scintillation counter. Cell
viability was determined by measuring lactate
dehydrogenase (LDH) levels in the culture
supernatants.
25
Treatment of 3H-RNA with RNase and KOH: For each
ml of 3H-RNA sample, 200 #1 of 0.3 N KOH or
17/ll of a mixture of ribonucleases (2 mg of RNase
type I-A + RNase T1 340058 IU/mg of protein)
were added. The tubes containing KOH were
boiled for 45 min, and those treated with the
enzymes were incubated at 37C for 30 min. The
samples were then processed for 3H-RNA detection
as described previously.
Sedimentation profile of3H-RNA The 3H-RNA present
in the supernatants from LPS-stimulated macro-
phage monolayers was treated with KOH or left
untreated, followed by cold ethanol precipitation
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for at least 16 h. The 3H-RNA from unstimulated
macrophage monolayers was precipitated with
ethanol alone. The H-RNAs were collected by
centrifugation (10000 g at 4C for 25 rain) and
resuspended in 0.05 M acetate buffer, pH 5.0.
Samples (100/A) were layered on linear 5-20%
sucrose gradients prepared in 0.05 M acetate buffer,
pH 5.0, containing 0.005 M EDTA. The gradients
were centrifuged at 53 000 x g" for 5 h at 4C and
fractionated using a density gradient fractionater.
The radioactivity of fractions collected was
quantified using a liquid scintillation spectrometer.
Materials: Thioglycollate medium and lipopoly-
saccharide from E. coli (0111 :B4) were purchased
from Difco Laboratories (Detroit, USA); RPMI
1640 medium from Flow Laboratories, USA; foetal
calf serum (FCS), L-glutamine, streptomycin,
penicillin, polymyxin B sulfate, bovine ribonuclease
T1, pancreatic ribonuclease, oligo(dT)-cellulose,
MTT, concanavalin-A, FMLP, ribonuclease T1 (EC
3.1.27.3; guanyloRNase) and bovine pancreatic
ribonuclease (EC 3.1.27.5; RNase type I-A) from
Sigma Co., USA; bis-acrylamide, acrylamide
(Merck); recombinant human IL-lfl, rhlL-6,
rhIL-8, rhTNF-0 were from the National Institute
for Biological Standards (Herts, UK). WEHI 164
clone 13 cells and rmuTNF- were a gift
from Dr M.A. Palladino Jr. (Genentech Inc., USA).
The anti-rmuTNF0 antibody was a gift from Dr
Wirla Tamashiro (State University of Campinas,
Brazil). 3H-Thymidine and [5-3H]-uridine were
from Amersham, UK.
Results
The preincubation of macrophage monolayers
with cytoplasmic RNA (25 ffg/ml) extracted from
LPS (10 g/ml) stimulated macrophages (L-RNA)
caused a significant release of TNF and IL-1 in the
culture medium as compared with the RNA from
non-stimulated macrophages (N-RNA), or with
RPMI medium alone (Fig. 1). Such cytokine release
was abolished by treatment of the L-RNA samples
with RNase but not with polymyxin B. Polymyxin
B at the same dose abolished the ability of LPS to
stimulate the release ofTNF and IL-1. The integrity
of our RNA samples was confirmed by SDS-poly-
acrylamide gel electrophoresis (data not shown).
The release of TNF (Fig. 2) and IL-1 (Fig. 3) by
macrophages was induced by both poly A(+) and
poly A(--) RNA fractions obtained by chroma-
tography of the L-RNA (total L-RNA) on oligo
(dT)--cellulose columns. Although the release of the
cytokines was of similar magnitude, the dose of
poly A(+) used was 50-fold less than that of poly
A(--) or total L-RNA. Figure 2a shows that the
TNF activity detected in supernatants of L-RNA
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FIG. 1. The effect of L-RNA and N-RNA on the release of TNF-a and IL-1
by resident macrophages. Macrophage monolayers were incubated with
N-RNA (25/l/ml), L-RNA (25/g/ml), LPS (10/g/ml) or RPMI medium
alone (C) for 6 h. The L-RNA was also incubated with RNase (2/g of
enzyme/10/g of L-RNA) or PMX (100#g/ml)" LPS was used as a
positive control. The activity of TNF- (panel A) and IL-1 (panel B) was
quantified as described in Materials and Methods. Results are given as
the mean _+ S.E.M. of quadruplicates from a representative assay taken
from three similar experiments. *p < 0.01 compared with control value
(ANOVA; Duncan’s test).
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FIG. 2. The effect of poly A(+)-RNA and poly A(-)-RNA fractions on
the release of TNF- by resident macrophages. Panel A" Macrophage
monolayers were incubated with total L-RNA (25/g/ml), or with the
poly A(+)- (0.5 #g/ml) or poly A(-)-RNA fractions (25/g/ml) for 6 h.
The supernatants were then incubated at 37C for 10 min prior to
performing the cytotoxicity assay with RPMI medium, rabbit anti-
rmuTNF- antibody or control antibody (serum from a non-immunized
rabbit). Panel B: A sample of rmuTNF-z was used as a control for the TNF
assay. Results are the mean ___
S.E.M. of at least two experiments
performed in quadruplicate. *p < 0.01 compared with control values
(ANOVA; Duncan’s test).
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FIG. 3. The effect of the poly A(+)-RNA and poly A(-)-RNA fractions
on the release of IL-1 by resident macrophages. Macrophage monolayers
were incubated with total L-RNA (25#g/ml), or with the poly
A(+)-RNA (0.5 #g/ml) or poly A(-)-RNA fractions (25 #g/ml) for 6 h.
Results are the mean _+ S.E.M. of quadruplicates from a representative
assay taken from three similar experiments.
stimulated macrophage monolayers was strongly
reduced by an antiserum against TNF- but not by
the control serum. The effect of TNF-cz antiserum
to recombinant murine TNF-0 is also shown in
Fig. 2b.
The preincubation of macrophage monolayers
with the inhibitors of protein synthesis cyclohex-
imide (10/.tg/ml) and actinomycin-D (10 #g/ml), or
with dexamethasone (3 #g/ml), a general inhibitor
of cytokine release, significantly blocked the
secretion of TNF induced by L-RNA (Fig. 4a).
The release of IL-1 by L-RNA stimulated
macrophages was also inhibited by cycloheximide
and by dexamethasone (Fig. 4b).
A radioactive material which precipitated with
TCA (Fig. 5) and which was sensitive to RNAse
(Fig. 6) was detected in the supernatants of
macrophage monolayers preincubated with [5-3H]
uridine and stimulated with LPS (10/.tg/ml) or
rlL-lfl (10
-8 M). These properties suggest that the
material was RNA. The release of radioactive RNA
was not observed in macrophage monolayers
stimulated with rTNF-0 (10-1-10
-8 M) or with
LPS in doses of 0.1 or 1 #g/ml, or with IL-lfl in
doses 10
-9 or 10-1M (Fig. 5). rIL-6 and rIL-8
(10--10
-8 M) were also ineffective in stimulating
the release of RNA (data not shown). The
sedimentation profile of the 3H-RNA released by
LPS-stimulated or non-stimulated, macrophage
monolayers in the sucrose gradient is shown in
Fig. 7. The 3H-RNAs secreted under both
conditions sediment in the same region of the
gradient (4-5 S). However, there was an increase in
3H-RNA secretion by macrophages treated with
LPS. Figure 7b shows that the 3H-RNA secreted by
LPS stimulated macrophages was completely
hydrolysed by KOH pretreatment. The sedimenta-
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Fig. 4. The effect of pretreatment of resident macrophages with cycloheximide, actinomycin-D and dexamethasone on the release of TNF- and IL-1
induced by L-RNA. Cycloheximide (CHX; 10#g/ml), actinomycin-D (ACT-D; 10#g/ml) or dexamethasone (DEX’ 3#g/ml) were added to RPMI
medium 30 min before the addition of L-RNA (25 #g/ml). Incubation time was 6 h. The TNF- activity (panel A) and the IL-1 activity (panel B) were
quantified as described in Materials and Methods. Results are the mean ___
S.E.M. of at least three experiments performed in quadruplicate. *p < 0.01
compared with control value (ANOVA; Duncan’s test).
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FIG. 5. The effect of LPS, rhulL-1 and rhuTNF- on the secretion of RNA
by resident macrophages. Macrophage monolayers were preincubated
with [5-3H]-uridine (5 #Ci/ml) for 2 h. This specific precursor of RNA
synthesis was then removed from the cultures and the cells were
incubated with LPS or recombinant human cytokines (rhulL-1 and
rhuTNF-) for 6 h. The supernatants were treated with TCA and
processed for 3H-RNA detection as described in Materials and Methods.
The results (counts per minute; cpm) are expressed as the mean -t- S.E.M.
of experiments performed in quadruplicate. *p < 0.05 compared with
control value (ANOVA; Duncan’s test).
tion profile of the non-radioactive, cytoplasmic
RNA is shown in Fig. 7a.
Incubation of the macrophage monolayers with
LPS or 1L-lfl in concentrations that stimulated
RNA secretion did not alter the viability of the
macrophages. Table 1 shows that the LDH activity
in the supernatants of macrophages before and after
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FIG. 6. The effect of RNase treatment of RNA secreted by macrophages
stimulated with LPS and rhulL-1. Macrophage monolayers were
preincubated with [5-3H]-uridine (5#Ci/ml) for 2 h. This specific
precursor of RNA synthesis was then removed from the cultures and the
cells were incubated with rhulL-1 (10-8 M) or LPS (10 #g/ml) for 6 h.
The supernatants were incubated with RNase TCA and processed for
3H-RNA detection as described in Materials and Methods. The results
(counts per minute, cpm) are expressed as the mean ___
S.E.M. of three
experiments performed in duplicate. *p < 0.05 compared with respective
control. (ANOVA; Student’s test).
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FIG. 7. Sedimentation profile of RNA secreted by normal or
LPS-stimulated macrophages. Panel A: Sedimentation profile of
non-radioactive RNA isolated from normal macrophages. Panel B:
Sedimentation profile of RNA secreted by macrophage mortlayers either
unstimulated or stimulated with LPS (10 #g/ml). The RNA secreted by
LPS stimulated macrophages was also hydrolyzed with KOH before
centrifugation on a 5-20% sucrose gradient. The experimental conditions
are given in Materials and Methods.
stimulation with LPS (10 #g/ml), IL-1/ (10
-8 M)
or TNF-g (10
-8 M) was not different from that
observed in the supernatant of macrophages
incubated with RPMI medium.
Discussion
The present study shows that macrophage
monolayers, when stimulated with L-RNA, release
Table 1. Detection of LDH activity in the supernatants of macro-
phage monolayers treated with LPS, rhulL-1 and rhuTNF-
Treatment
LDH activity (units/ml/min)
Before treatment After treatment (6 h)
Medium 0.173 0.184
LPS (10 #g/ml) 0.172 0.106
rhulL-lfl (10-8 M) 0.161 0.172
rhuTNF- (10
-8 M) 0.192 0.147
Data are the means of two experiments.
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IL-1 and TNF-o into the supernatant, and that
macrophages pre-incubated with [5-3H]-uridine, a
specific precursor of RNA synthesis, release
3H-RNA into the culture supernatant when
stimulated with LPS or IL-lfl. These data suggest
that exogenous RNA may mediate secretion of
cytokines by resting macrophages.
The L-RNA-induced release of cytokines by
macrophages is assumed to be RNA specific and
not due to LPS contamination, because: (a) this
effect is strongly reduced by ribonuclease; (b)
N-RNA has no biological effects, thus indicating
that the polynucleotide chain by itself is not able to
induce cytokine release; and (c) polymyxin B, in a
dose that inhibits LPS-induced release of IL-1 and
TNFo, does not modify L-RNA activity.
There is much evidence showing that poly
A(+)-RNA is the main active biological fraction of
exogenous RNA11’20’26’27 despite some findings
showing a functional effect for poly A(--)-RNA.
28
In an attempt to identify the fraction of L-RNA
active in cytokine release, total cytoplasmic L-RNA
samples were fractionated by oligo (dT)-cellulose
chromatography and the activity of the poly
a(+)- and poly A(--)-RNA fractions on IL-1 and
TNF- release were studied. The poly A(+)-RNA
(0.5/,g/ml), poly A(--)-RNA (25/g/ml) and total
L-RNA (25 #g/ml) had similar effects on the release
of the two cytokines.
It is known that poly A(+) containing RNA is
the messenger RNA fraction and comprises about
1-2% of the total cellular RNA of eukaryotic cells.
19
In our experiments the dose of poly A(+) that
induced the release of TNF-o and IL-1 (0.5/g/ml)
corresponds to 2% of the dose of the total L-RNA
that also induced cytokine release. This finding is
strong evidence that at least part of the L-RNA acts
as informational RNA. Corroborating this idea is
the fact that cycloheximide, an inhibitor of RNA
translation in eukaryotic cells,
29 inhibited the release
of TNF-o and IL-1 by L-RNA-stimulated macro-
phages. The release of these cytokines was also
found in the poly A(--)-RNA treated macrophages,
suggesting that L-RNA may also act at the
transcriptional level. The inhibition of L-RNA
activity by actinomycin-D, a classical inhibitor of
transcription, confirms this assumption.
It is known that the release of cytokines
stimulated by different stimuli is strongly inhibited
by glucocorticoids acting at the transcriptional
and/or translational levels.
3-32 In our experiments
dexamethasone blocked the release of IL-1 and
TNF from the L-RNA stimulated macrophages
which is additional evidence that L-RNA may act
at the transcriptional and/or translational levels.
It is now accepted that resident macrophages may
act as alarm cells.
33 These cells are highly reactive
and, when activated by various stimuli, secrete
several mediators including cytokines, which play
an important role in triggering and maintaining the
defence response. 14’1s In the first part of this paper
the authors show that the RNA obtained from
LPS-activated macrophages can mediate cytokine
release. In the second part of this work, it is shown
that these macrophages, when pre-incubated with
[5-3H]-uridine and activated with LPS, released a
radioactive, TCA-precipitable material into the
supernatant which was hydrolysed by RNase and
KOH. It is assumed therefore, that these radioactive
macromolecules represent RNA which sediments in
the 4-5 S region of the sucrose gradient. There are
a few reports in the literature24’34’35 concerning the
release by eukaryotic cells ofRNA which sediments
in the 2.5-5.0 S region of the sucrose gradient. The
present observation is the first demonstration that
eukaryotic cells release RNA after an exogenous
stimulus such as LPS, since previous reports
concern spontaneously released RNA.
One interesting finding was that RNA secretion
is also induced by an endogenous, pro-infl-
ammatory mediator, IL-lfl, but not by IL-6, IL-8
or TNF-z, suggesting that the release is mediator
specific. That RNA secretion may be due to cellular
damage was eliminated by the demonstration of cell
viability by eosin Y exclusion and by the
measurement of lactate dehydrogenase activity in
the supernatants of the LPS- and cytokine-
stimulated macrophages. Together, the facts that
RNA obtained from activated macrophages can
stimulate cytokine release by resting macrophages,
and that activated macrophages also release RNA,
provide experimental evidence for the concept that
RNA may be an intercellular mediator. To obtain
further insight concerning the implications ofRNA
secretion, the biological activity of such secreted
RNA is currently under investigation.
In conclusion, our data suggest that resident
macrophages, when stimulated by injurious stimuli,
in addition to secreting cytokines, are also able to
release RNA which may act on the surrounding,
resting macrophages, thus stimulating the release of
more cytokines. This process may represent
amplification of the mechanisms involved in
defence responses.
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